JAGDEEP KAHLON: Open Payments
NPI 1669633319 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 65 payments from 14 companies in 2025. Trend: 2023 $1,565 · 2024 $1,796 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $461 |
| Neurocrine BioSciences, Inc. | 9 | $374 |
| ABBVIE INC. | 10 | $288 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
| Lundbeck LLC | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Alkermes, Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
Products named: COBENFY, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, TRINTELLIX, REXULTI, ARISTADA, Auvelity.
Industry payments across VA — which companies pay providers there.
